Open links in new tab
  1. CNN
    https://www.cnn.com › health › first-rsv-vaccine-approved

    FDA approves first vaccine for RSV, a …

    • In a clinical trial of nearly 25,000 older adults, the results of which were published in the New England Journal of Medicine, the GSK vaccine was 83% effective at preventing lower respiratory tract disease cause… See more

    More RSV Vaccines on The Way

    Three other RSV vaccines for older adults are also in the final phases of testing. The … See more

    CNN
    Scientific Triumph After Tragedy

    The hunt for an effective vaccine for RSV is a story of scientific triumph over tragedy. In the 1960s, two children died and many others were hospitalized with severe RSV when the e… See more

    CNN
    RSV is straining some hospitals, and US ... - Associated Press News
    RSV, or respiratory syncytial virus, is a common cause of mild cold-like symptoms such as runny nose, cough and fever. Still, it can be dangerous for infants and older people. The CDC esti…
    AP News · https://apnews.com/article/rsv-surg…
    Feedback
    Table of Contents
    More RSV Vaccines on The Way
    Scientific Triumph After Tragedy
     
  2. NIH MedlinePlus Magazine
    https://magazine.medlineplus.gov › article › a-new...

    A new vaccine is here to protect you and your loved ones from …

  3. AP News
    https://apnews.com › article

    Guillain-Barre syndrome 'more common than ... - Associated Press …

  4. AP News
    https://apnews.com › article

    RSV is straining some hospitals, and US ... - Associated Press News

  5. News-Medical.net
    https://www.news-medical.net › news › New...

    New approach to stabilize RSV protein could lead to better vaccines

  6. AP News
    https://apnews.com › article

    US approves 1st vaccine for RSV after decades of attempts

  7. People also ask
    Can you get a respiratory syncytial virus in December?
    December and January are peak months for respiratory syncytial virus (RSV) infections. While anyone can get RSV, severe infections are more common in young children and older adults. Fortunately, new vaccine approvals by the U.S. Food and Drug Administration (FDA) mean there are more options to avoid getting sick this winter.

    A new vaccine is here to protect you and your loved ones from RSV this

    magazine.medlineplus.gov
    What are the virulence factors of respiratory syncytial virus and how do they affect the host?

    Dr. Spoorthi Prakash

    MBBS · 8 years of exp

    The human respiratory syncytial virus is one of the most common respiratory viruses affecting children and elderly and results in large out-patient visits and admissions every year. There are various strategies that virus incorporates the host immune system, thus spreading more easily which is called virulence. There are various modifications of the proteins inside the virus, which makes the host not recognize and fight the virus, thus virus spreads without any opposition and causes long time effects like asthma and allergic bronchitis.
    Q&A: Human Respiratory Syncytial Virus
    bing.com
    Is a surge in respiratory syncytial virus infections affecting healthcare systems?
    A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in northern climes, has strained already fragile healthcare systems that are also coping with the influenza season and COVID-19.

    Progress at last against RSV - Nature Medicine

    nature.com
    What does a human respiratory syncytial virus (RSV) image show?
    FILE - This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus (RSV) virions, colorized blue, and anti-RSV F protein/gold antibodies, colorized yellow, shedding from the surface of human lung cells.

    Guillain-Barre syndrome 'more common than expected' with RSV vaccin…

    apnews.com
    When is a peak month for respiratory syncytial virus (RSV) infections?
    December and January are peak months for respiratory syncytial virus (RSV) infections. NIH MedlinePlus Magazine has a handy overview of RSV, how it spreads, and how to protect yourself and others from getting sick. Learn what immunizations are available, including vaccines for older adults and antibodies for infants.

    A new vaccine is here to protect you and your loved ones from RSV this

    magazine.medlineplus.gov
    What morphology does a human respiratory syncytial virus exhibit?
    This highly-magnified, 1981 transmission electron microscopic (TEM) image, reveals some of the morphologic traits exhibited by a human respiratory syncytial virus (RSV). The virion is variable in shape, and size, with an average diameter between 120-300nm.

    FDA approves first vaccine for RSV, a moment six decades in the ... - CNN

    cnn.com
    Feedback
  8. ScienceDaily
    https://www.sciencedaily.com › releases

    Researchers use biophysics to design new vaccines against RSV …

  9. Nature
    https://www.nature.com › articles

    Progress at last against RSV | Nature Medicine

  10. Medical Xpress
    https://medicalxpress.com › tags › respiratory+syncytial+virus

    Respiratory Syncytial Virus - latest research news and features

  11. Nature
    https://www.nature.com › articles

    Vaccines could offer fresh hope against …

    Sep 27, 2023 · In the United States alone, RSV-related hospitalizations tripled in November 2022 relative to the pre-pandemic levels three years before. Paediatricians have …